Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma, Proceedings of the National Academy of Sciences, vol.77, issue.12, pp.7415-7419, 1980. ,
DOI : 10.1073/pnas.77.12.7415
Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy, J Virol, vol.69, pp.2863-2868, 1995. ,
An HTLV-I Vaccine: Why, How, for Whom?, AIDS Research and Human Retroviruses, vol.9, issue.5, pp.381-386, 1993. ,
DOI : 10.1089/aid.1993.9.381
The prevalence of human T-cell lymphotropic virus type 1 in the general population is unknown, AIDS Rev, vol.11, pp.205-214, 2009. ,
Human T-lymphotropic virus 1: recent knowledge about an ancient infection, The Lancet Infectious Diseases, vol.7, issue.4, pp.266-281, 2007. ,
DOI : 10.1016/S1473-3099(07)70081-6
The immune control and cell-to-cell spread of human T-lymphotropic virus type 1, Journal of General Virology, vol.84, issue.12, pp.3177-3189, 2003. ,
DOI : 10.1099/vir.0.19334-0
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS), Neurology, vol.33, issue.11, pp.1444-1452, 1983. ,
DOI : 10.1212/WNL.33.11.1444
HTLV-I-associated myelopathy (HAM): treatment trials, retrospective survey, and clinical and laboratory findings, Hematol Rev, vol.3, pp.271-284, 1990. ,
Immunocytochemical Analysis of the Cellular Infiltrate in the Spinal Cord Lesions in HTLV-I-Associated Myelopathy, Journal of Neuropathology and Experimental Neurology, vol.52, issue.4, pp.424-430, 1993. ,
DOI : 10.1097/00005072-199307000-00010
Therapeutic trials in 200 patients with HTLV-Iassociated myelopathy/tropical spastic paraparesis, Journal of Neurovirology, vol.2, issue.5, pp.345-355, 1996. ,
DOI : 10.3109/13550289609146899
Treatment of HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis: Toward Rational Targeted Therapy, Neurologic Clinics, vol.26, issue.3, pp.781-797, 2008. ,
DOI : 10.1016/j.ncl.2008.03.008
Histone deacetylase mediated transcriptional activation reduces proviral loads in HTLV-1 associated myelopathy/tropical spastic paraparesis patients, Blood, vol.110, issue.10, pp.3722-3728, 2007. ,
DOI : 10.1182/blood-2007-04-085076
Zidovudine plus lamivudine in human T-lymphotropic virus type-I-associated myelopathy: a randomised trial, Retrovirology, vol.3, issue.1, p.63, 2006. ,
DOI : 10.1186/1742-4690-3-63
The impact of interferon-alpha treatment on clinical and immunovirological aspects of HTLV-1-associated myelopathy in northeast of Iran, Journal of Neuroimmunology, vol.250, issue.1-2, pp.87-93, 2012. ,
DOI : 10.1016/j.jneuroim.2012.05.004
Interferon-?1a therapy in human T-lymphotropic virus type I-associated neurologic disease, Annals of Neurology, vol.168, issue.4, pp.526-534, 2005. ,
DOI : 10.1002/ana.20429
Frequent clonal proliferation of human T-cell leukemia virus type 1 (HTLV-1)-infected T cells in HTLV-1-associated myelopathy (HAM-TSP), Blood, vol.80, pp.1012-1016, 1992. ,
Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: Alternate molecular mechanisms underlying retroviral pathogenesis, Journal of Cellular Biochemistry, vol.26, issue.4, pp.302-311, 1991. ,
DOI : 10.1002/jcb.240460405
Analysis Of Htlv-I Proviral Load In 202 Ham/Tsp Patients And 243 Asymptomatic Htlv-I Carriers: High Proviral Load Strongly Predisposes To Ham/Tsp, Journal of Neurovirology, vol.4, issue.6, pp.586-593, 1998. ,
DOI : 10.3109/13550289809114225
Cerebrospinal fluid interferon-gamma is increased in HTLV-I-associated myelopathy, Journal of Neuroimmunology, vol.42, issue.2, pp.223-226, 1993. ,
DOI : 10.1016/0165-5728(93)90014-P
Detection of tumor necrosis factor-alpha-positive cells in cerebrospinal fluid of patients with HTLV-I-associated myelopathy, pp.127-130, 1993. ,
Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy/tropical spastic paraparesis, Journal of the Neurological Sciences, vol.97, issue.2-3, pp.183-193, 1990. ,
DOI : 10.1016/0022-510X(90)90217-B
Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4+ T cells, Nature Medicine, vol.174, issue.4, pp.429-436, 2008. ,
DOI : 10.1182/blood.V99.1.88
In Vivo Infection of Human T-Cell Leukemia Virus Type I in Non-T Cells, Virology, vol.196, issue.1, pp.25-33, 1993. ,
DOI : 10.1006/viro.1993.1451
The role of B7 costimulation in T-cell immunity, Immunology and Cell Biology, vol.77, issue.4, pp.304-311, 1999. ,
DOI : 10.1084/jem.185.1.177
Delayed and Separate Costimulation In Vitro Supports the Evidence of a Transient "Excited" State of CD8+ T Cells During Activation, The Journal of Immunology, vol.164, issue.9, pp.4493-4499, 2000. ,
DOI : 10.4049/jimmunol.164.9.4493
Costimulatory effects of T cell proliferation during infection with human T lymphotropic virus types I and II are mediated through CD80 and CD86 ligands, J Immunol, vol.157, pp.1288-1296, 1996. ,
HTLV-I-infected T cells activate autologous CD4+ T cells susceptible to HTLV-I infection in a co-stimulatory molecule-dependent fashion, European Journal of Immunology, vol.69, issue.6, pp.1427-1432, 1997. ,
DOI : 10.1002/eji.1830270620
Studies in B7-Deficient Mice Reveal a Critical Role for B7 Costimulation in Both Induction and Effector Phases of Experimental Autoimmune Encephalomyelitis, The Journal of Experimental Medicine, vol.161, issue.5, pp.733-740, 1999. ,
DOI : 10.1084/jem.186.9.1585
Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis., Journal of Clinical Investigation, vol.96, issue.5, pp.2195-2203, 1995. ,
DOI : 10.1172/JCI118274
Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE, Immunity, vol.3, issue.6, pp.739-745, 1995. ,
DOI : 10.1016/1074-7613(95)90063-2
Reactive astrocytes in chronic active lesions of multiple sclerosis express co-stimulatory molecules B7-1 and B7-2, Journal of Neuroimmunology, vol.135, issue.1-2, pp.166-171, 2003. ,
DOI : 10.1016/S0165-5728(02)00462-9
Types I and II interferons upregulate the costimulatory CD80 molecule in monocytes via interferon regulatory factor-1, Biochemical Pharmacology, vol.78, issue.5, pp.514-522, 2009. ,
DOI : 10.1016/j.bcp.2009.05.005
URL : https://hal.archives-ouvertes.fr/hal-00497271
Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy., Journal of Clinical Investigation, vol.99, issue.11, pp.2664-2671, 1997. ,
DOI : 10.1172/JCI119455
Effects of interferon-?? on co-signaling molecules: upregulation of CD40, CD86 and PD-L2 on monocytes in relation to clinical response to interferon-?? treatment in patients with multiple sclerosis, Multiple Sclerosis, vol.14, issue.2, pp.166-176, 2008. ,
DOI : 10.1177/1352458507081342
IFN-?? treatment modulates the CD28/CTLA-4-mediated pathway for IL-2 production in patients with relapsing???remitting multiple sclerosis, Multiple Sclerosis, vol.10, issue.6, pp.630-635, 2004. ,
DOI : 10.1191/1352458504ms1094oa
Beta-interferon for multiple sclerosis, Experimental Cell Research, vol.317, issue.9, pp.1301-1311, 2011. ,
DOI : 10.1016/j.yexcr.2011.03.002
Interferon-alpha is effective in HTLV-I-associated myelopathy: A multicenter, randomized, double-blind, controlled trial, Neurology, vol.46, issue.4, pp.1016-1021, 1996. ,
DOI : 10.1212/WNL.46.4.1016
Interferon-alpha treatment in HTLV-I-associated myelopathy, Journal of the Neurological Sciences, vol.106, issue.2, pp.186-192, 1991. ,
DOI : 10.1016/0022-510X(91)90256-7
Review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP, 1990. ,
Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP, Journal of Medical Virology, vol.2, issue.7, pp.1269-1274, 2011. ,
DOI : 10.1002/jmv.22087
SYBR Green???based quantitation of human T-lymphotropic virus type 1 proviral load in Peruvian patients with neurological disease and asymptomatic carriers: Influence of clinical status, sex, and familial relatedness, Journal of Neurovirology, vol.12, issue.6, pp.456-465, 2006. ,
DOI : 10.1080/13550280601039634
HTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM/TSP patients: A marker of disease progression, Journal of the Neurological Sciences, vol.237, issue.1-2, pp.53-59, 2005. ,
DOI : 10.1016/j.jns.2005.05.010
Clinical Characteristics of Patients in Peru with Human T Cell Lymphotropic Virus Type 1???Associated Tropical Spastic Paraparesis, Clinical Infectious Diseases, vol.39, issue.7, pp.939-944, 2004. ,
DOI : 10.1086/423957
Gender influence on the progression of HTLV-I associated myelopathy/tropical spastic paraparesis, Journal of Neurology, Neurosurgery & Psychiatry, vol.76, issue.2, pp.294-296, 2005. ,
DOI : 10.1136/jnnp.2004.035709
Human T cell leukemia virus type 1 infection drives spontaneous proliferation of natural killer cells, Virulence, vol.1, issue.1, pp.19-28, 2010. ,
DOI : 10.1128/JVI.00887-07
Frequent reversible membrane damage in peripheral blood B cells in human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP), Clinical and Experimental Immunology, vol.1, issue.2, pp.307-316, 2000. ,
DOI : 10.1007/s000180050067
Immunomodulatory effects of interferon beta-1a in multiple sclerosis, Journal of Neuroimmunology, vol.112, issue.1-2, pp.153-162, 2001. ,
DOI : 10.1016/S0165-5728(00)00403-3
B Cells as a Therapeutic Target for IFN-?? in Relapsing-Remitting Multiple Sclerosis, The Journal of Immunology, vol.186, issue.7, pp.4518-4526, 2011. ,
DOI : 10.4049/jimmunol.1000271
In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP), Retrovirology, vol.6, issue.1 ,
DOI : 10.1186/1742-4690-6-19
Abnormally High Levels of Virus-Infected IFN-??+CCR4+CD4+CD25+ T Cells in a Retrovirus-Associated Neuroinflammatory Disorder, PLoS ONE, vol.79, issue.10, p.6517, 2009. ,
DOI : 10.1371/journal.pone.0006517.s002
Expression of CD80/86 on B cells is essential for autoreactive T cell activation and the development of arthritis, J Immunol, vol.179, pp.5109-5116, 2007. ,
Activated memory B cells may function as antigen-presenting cells in the joints of children with juvenile idiopathic arthritis, Arthritis & Rheumatism, vol.224, issue.11, pp.3458-3466, 2011. ,
DOI : 10.1002/art.30569
B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy, Cell, vol.80, issue.5, pp.707-718, 1995. ,
DOI : 10.1016/0092-8674(95)90349-6
T helper differentiation in resistant and susceptible B7-deficient mice infected with Leishmania major, European Journal of Immunology, vol.32, issue.6, pp.1764-1772, 2002. ,
DOI : 10.1002/1521-4141(200206)32:6<1764::AID-IMMU1764>3.0.CO;2-V
Leishmania major induces differential expression of costimulatory molecules on mouse epidermal cells, European Journal of Immunology, vol.31, issue.5, pp.1400-1409, 2001. ,
DOI : 10.1002/1521-4141(200105)31:5<1400::AID-IMMU1400>3.0.CO;2-J
Association of B7-1 Co-Stimulation with the Development of Graft Arterial Disease, The American Journal of Pathology, vol.157, issue.2, pp.473-484, 2000. ,
DOI : 10.1016/S0002-9440(10)64559-2
Sepsis-Induced Changes in Macrophage Co-Stimulatory Molecule Expression: CD86 as a Regulator of Anti-Inflammatory IL-10 Response, Surgical Infections, vol.5, issue.4, pp.375-383, 2004. ,
DOI : 10.1089/sur.2004.5.375
Differential Role for CD80 and CD86 in the Regulation of the Innate Immune Response in Murine Polymicrobial Sepsis, PLoS ONE, vol.177, issue.8, p.6600, 2009. ,
DOI : 10.1371/journal.pone.0006600.t001
CD40 and CD80/86 Act Synergistically to Regulate Inflammation and Mortality in Polymicrobial Sepsis, American Journal of Respiratory and Critical Care Medicine, vol.177, issue.3, pp.301-308, 2008. ,
DOI : 10.1164/rccm.200703-515OC
Costimulatory CD80 (B7-1) and CD86 (B7-2) on cerebrospinal fluid cells in multiple sclerosis, Journal of Neuroimmunology, vol.84, issue.2, pp.179-187, 1998. ,
DOI : 10.1016/S0165-5728(97)00261-0
Increased expression of B7-1 costimulatory molecule on cerebrospinal fluid cells of patients with multiple sclerosis and infectious central nervous system disease, Journal of Neuroimmunology, vol.75, issue.1-2, pp.59-68, 1997. ,
DOI : 10.1016/S0165-5728(96)00234-2
Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions, Journal of Experimental Medicine, vol.182, issue.6, pp.1985-1996, 1995. ,
DOI : 10.1084/jem.182.6.1985
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis, Nature, vol.48, issue.7359, pp.214-219, 2011. ,
DOI : 10.1038/nature10251
URL : https://hal.archives-ouvertes.fr/hal-00996686
PD-1 and Its Ligands in Tolerance and Immunity, Annual Review of Immunology, vol.26, issue.1, pp.677-704, 2008. ,
DOI : 10.1146/annurev.immunol.26.021607.090331
THE B7???CD28 SUPERFAMILY, Nature Reviews Immunology, vol.12, issue.2, pp.116-126, 2002. ,
DOI : 10.1038/35069118
The Elevated Interferon Gamma Production is an Important Immunological Marker in HAM/TSP Pathogenesis, Scandinavian Journal of Immunology, vol.269, issue.suppl 2, pp.403-407, 2009. ,
DOI : 10.1111/j.1365-3083.2009.02291.x
Effect of TNF-?? production inhibitors on the production of pro-inflammatory cytokines by peripheral blood mononuclear cells from HTLV-1-infected individuals, Brazilian Journal of Medical and Biological Research, vol.44, issue.11, pp.1134-1140, 2011. ,
DOI : 10.1590/S0100-879X2011007500140
Ascorbic Acid Has Superior Ex Vivo Antiproliferative, Cell Death-Inducing and Immunomodulatory Effects over IFN-?? in HTLV-1-Associated Myelopathy, PLoS Neglected Tropical Diseases, vol.113, issue.7, p.1729, 2012. ,
DOI : 10.1371/journal.pntd.0001729.s001
Interferon gamma responses to myelin peptides in multiple sclerosis correlate with a new clinical measure of disease progression, Journal of Neuroimmunology, vol.141, issue.1-2, pp.132-140, 2003. ,
DOI : 10.1016/S0165-5728(03)00221-2
EXACERBATIONS OF MULTIPLE SCLEROSIS IN PATIENTS TREATED WITH GAMMA INTERFERON, The Lancet, vol.329, issue.8538, pp.893-895, 1987. ,
DOI : 10.1016/S0140-6736(87)92863-7
Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation., Journal of Clinical Investigation, vol.95, issue.6, pp.2783-2789, 1995. ,
DOI : 10.1172/JCI117982
B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance, Blood, vol.116, issue.8, pp.1291-1298, 2010. ,
DOI : 10.1182/blood-2010-01-265975
Prevention of Experimental Autoimmune Encephalomyelitis by Transfer of Embryonic Stem Cell-Derived Dendritic Cells Expressing Myelin Oligodendrocyte Glycoprotein Peptide along with TRAIL or Programmed Death-1 Ligand, The Journal of Immunology, vol.174, issue.4, pp.1888-1897, 2005. ,
DOI : 10.4049/jimmunol.174.4.1888
A cell type-specific enhancer in the human B7.1 gene regulated by NF- kappaB, Journal of Experimental Medicine, vol.183, issue.3, pp.777-789, 1996. ,
DOI : 10.1084/jem.183.3.777
The IRF family, revisited, Biochimie, vol.89, issue.6-7, pp.744-753, 2007. ,
DOI : 10.1016/j.biochi.2007.01.014
Dissecting Interferon-Induced Transcriptional Programs in Human Peripheral Blood Cells, PLoS ONE, vol.5, issue.3, p.9753, 2010. ,
DOI : 10.1371/journal.pone.0009753.s010
Activators and target genes of Rel/NF-??B transcription factors, Oncogene, vol.18, issue.49, pp.6853-6866, 1999. ,
DOI : 10.1038/sj.onc.1203239
TNF-R1 Signaling: A Beautiful Pathway, Science, vol.296, issue.5573, pp.1634-1635, 2002. ,
DOI : 10.1126/science.1071924
Cloning and functional characterization of the 5???-regulatory region of the human CD86 gene, Human Immunology, vol.61, issue.5, pp.486-498, 2000. ,
DOI : 10.1016/S0198-8859(00)00099-9
Systemic ??-Interferon in Multiple Sclerosis, Archives of Neurology, vol.44, issue.1, pp.61-63, 1987. ,
DOI : 10.1001/archneur.1987.00520130047016
HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells, Proceedings of the National Academy of Sciences, vol.103, issue.3, pp.720-725, 2006. ,
DOI : 10.1073/pnas.0507631103
Role of tax protein in human T-cell leukemia virus type-I leukemogenicity, Retrovirology, vol.1, issue.1, p.20, 2004. ,
DOI : 10.1186/1742-4690-1-20
Astrocytic Alterations Induced by HTLV Type 1-Infected T Lymphocytes: A Role for Tax-1 and Tumor Necrosis Factor ??, AIDS Research and Human Retroviruses, vol.16, issue.16, pp.1723-1729, 2000. ,
DOI : 10.1089/08892220050193218
Human T-Cell Lymphotropic Virus Type 1-Infected T Lymphocytes Impair Catabolism and Uptake of Glutamate by Astrocytes via Tax-1 and Tumor Necrosis Factor Alpha, Journal of Virology, vol.74, issue.14, pp.6433-6441, 2000. ,
DOI : 10.1128/JVI.74.14.6433-6441.2000
The human interferon-?? gene contains an inducible promoter that can be transactivated by tax I and II, European Journal of Immunology, vol.48, issue.8, pp.1879-1885, 1991. ,
DOI : 10.1002/eji.1830210815
CD4+ T Cell Expressed CD80 Regulates Central Nervous System Effector Function and Survival during Experimental Autoimmune Encephalomyelitis, The Journal of Immunology, vol.177, issue.5, pp.2948-2958, 2006. ,
DOI : 10.4049/jimmunol.177.5.2948
Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis, Clinical and Experimental Immunology, vol.103, issue.3, pp.499-506, 2004. ,
DOI : 10.1016/S0165-5728(00)00403-3
Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers, BMC Infectious Diseases, vol.43, issue.5, 2004. ,
DOI : 10.1046/j.1365-3083.1996.d01-9.x
Free HTLV-1 induces TLR7-dependent innate immune response and TRAIL relocalization in killer plasmacytoid dendritic cells, Blood, vol.115, issue.11, pp.2177-2185, 2010. ,
DOI : 10.1182/blood-2009-06-224741
URL : https://hal.archives-ouvertes.fr/hal-00456470
Systems Biology Approaches Reveal a Specific Interferon-Inducible Signature in HTLV-1 Associated Myelopathy, PLoS Pathogens, vol.37, issue.1, p.1002480, 2012. ,
DOI : 10.1371/journal.ppat.1002480.s014
Interferon-?? significantly reduces cerebrospinal fluid CD4 cell subsets in HAM/TSP, Journal of Neuroimmunology, vol.141, issue.1-2, pp.170-173, 2003. ,
DOI : 10.1016/S0165-5728(03)00219-4
Protective effect of interferon ? on human T cell leukaemia virus type I infection of CD4+ T cells isolated from human cord blood, Cancer Immunology Immunotherapy, vol.81, issue.2, pp.97-104, 1993. ,
DOI : 10.1007/BF01517041
Depression of early phase of HTLV-I infection in vitro mediated by human beta-interferon, British Journal of Cancer, vol.57, issue.5, pp.481-488, 1988. ,
DOI : 10.1038/bjc.1988.111
Long-term experience with interferon beta-1b (Betaferon??) in multiple sclerosis, Journal of Neurology, vol.77, issue.S3, pp.28-33, 2005. ,
DOI : 10.1007/s00415-005-2014-2
Interferon-?? treatment for relapsing multiple sclerosis, Expert Opinion on Biological Therapy, vol.13, issue.9, pp.1435-1447, 2008. ,
DOI : 10.1053/jhep.2001.26371
Interferon-??-1b, CNS Drugs, vol.122, issue.1, pp.787-792, 2008. ,
DOI : 10.2165/00023210-200822090-00005
Changes of percentages in immune cells phenotypes and cytokines production during two-year IFN-?-1a treatment in multiple sclerosis patients, Journal of Neurology, vol.250, issue.10, pp.1229-1236, 2003. ,
DOI : 10.1007/s00415-003-0170-9
Antagonism of interferon beta on interferon gamma: inhibition of signal transduction in vitro and reduction of serum levels in multiple sclerosis patients, Mult Scler, vol.1, issue.1, pp.5-11, 1995. ,
Interferon ?? decreases T cell activation and interferon ?? production in multiple sclerosis, Journal of Neuroimmunology, vol.46, issue.1-2, pp.145-153, 1993. ,
DOI : 10.1016/0165-5728(93)90244-S
Antagonistic action of IFN-beta and IFN-gamma on high affinity Fc gamma receptor expression in healthy controls and multiple sclerosis patients, J Immunol, vol.161, pp.1568-1574, 1998. ,
Human T-cell leukemia virus type 1 bZIP factor selectively suppresses the classical pathway of NF-??B, Blood, vol.113, issue.12, pp.2755-2764, 2009. ,
DOI : 10.1182/blood-2008-06-161729
Making Sense out of Antisense Transcription in Human T-Cell Lymphotropic Viruses (HTLVs), Viruses, vol.3, issue.12, pp.456-468, 2011. ,
DOI : 10.3390/v3050456
Interferon-?? in multiple sclerosis: altering the balance of interleukin-12 and interleukin-10?, Current Opinion in Neurology, vol.14, issue.3, pp.361-368, 2001. ,
DOI : 10.1097/00019052-200106000-00016
IFN-??-1b Inhibits IL-12 Production in Peripheral Blood Mononuclear Cells in an IL-10-Dependent Mechanism: Relevance to IFN-??-1b Therapeutic Effects in Multiple Sclerosis, The Journal of Immunology, vol.165, issue.1, pp.548-557, 2000. ,
DOI : 10.4049/jimmunol.165.1.548
Comparable potency of IFN??2 and IFN?? on immediate JAK/STAT activation but differential down-regulation of IFNAR2, Biochemical Journal, vol.407, issue.1, pp.141-151, 2007. ,
DOI : 10.1042/BJ20070605
URL : https://hal.archives-ouvertes.fr/hal-00478796
Mutational Analysis of the IFNAR1 Binding Site on IFN??2 Reveals the Architecture of a Weak Ligand???Receptor Binding-site, Journal of Molecular Biology, vol.353, issue.2, pp.271-281, 2005. ,
DOI : 10.1016/j.jmb.2005.08.042
Differential Use of the beta L Subunit of the Type I Interferon (IFN) Receptor Determines Signaling Specificity for IFNalpha 2 and IFNbeta, Journal of Biological Chemistry, vol.273, issue.6, pp.3144-3147, 1998. ,
DOI : 10.1074/jbc.273.6.3144
Structural basis of a unique interferon-?? signaling axis mediated via the receptor IFNAR1, Nature Immunology, vol.180, issue.9, pp.901-907, 2013. ,
DOI : 10.4049/jimmunol.0902314
HOW CELLS RESPOND TO INTERFERONS, Annual Review of Biochemistry, vol.67, issue.1, pp.227-264, 1998. ,
DOI : 10.1146/annurev.biochem.67.1.227
The protein tyrosine kinase JAK1 complements defects in
interferon-??/?? and -?? signal transduction, Nature, vol.366, issue.6451, pp.129-135, 1993. ,
DOI : 10.1038/366129a0
A protein tyrosine kinase in the interferon ???? signaling pathway, Cell, vol.70, issue.2, pp.313-322, 1992. ,
DOI : 10.1016/0092-8674(92)90105-L
Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway., Molecular and Cellular Biology, vol.9, issue.11, pp.4605-4612, 1989. ,
DOI : 10.1128/MCB.9.11.4605
Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility, Brain, vol.134, issue.3, pp.693-703, 2011. ,
DOI : 10.1093/brain/awr010
Activation of the Jak-Stat Pathway in Cells That Exhibit Selective Sensitivity to the Antiviral Effects of IFN-beta Compared with IFN-alpha, Journal of Interferon & Cytokine Research, vol.19, issue.7, pp.797-801, 1999. ,
DOI : 10.1089/107999099313659
Comparison of gene expression patterns induced by treatment of human umbilical vein endothelial cells with IFN-alpha 2b vs. IFN-beta 1a: understanding the functional relationship between distinct type I interferons that act through a common receptor ,
IFN-?? induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7, Oncogene, vol.19, issue.30, pp.3372-3383, 2000. ,
DOI : 10.1038/sj.onc.1203670
Type I IFN Receptor Signals Directly Stimulate Local B Cells Early following Influenza Virus Infection, The Journal of Immunology, vol.176, issue.7, pp.4343-4351, 2006. ,
DOI : 10.4049/jimmunol.176.7.4343
A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells, Nature, vol.78, issue.7312, pp.214-217, 2010. ,
DOI : 10.1038/nature09337
The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice, Journal of Clinical Investigation, vol.118, issue.5, pp.1680-1690, 2008. ,
DOI : 10.1172/JCI33342
Issazadeh-Navikas S: IFN-beta gene deletion leads to ,
Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c+ B-cell population is important for the development of autoimmunity, Blood, vol.118, issue.5, pp.1305-1315, 2011. ,
DOI : 10.1182/blood-2011-01-331462
Reprogrammed quiescent B cells provide an effective cellular therapy against chronic experimental autoimmune encephalomyelitis, European Journal of Immunology, vol.33, issue.6, pp.1696-1708, 2011. ,
DOI : 10.1002/eji.201041041
Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced na??ve/memory Breg ratio during a relapse but not in remission, Journal of Neuroimmunology, vol.239, issue.1-2, pp.80-86, 2011. ,
DOI : 10.1016/j.jneuroim.2011.08.019
Establishing Phenotypic Features Associated with Morbidity in Human T-Cell Lymphotropic Virus Type 1 Infection, Clinical and Vaccine Immunology, vol.11, issue.6, pp.1105-1110, 2004. ,
DOI : 10.1128/CDLI.11.6.1105-1110.2004
Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients, Journal of Neuroimmunology, vol.180, issue.1-2, pp.63-70, 2006. ,
DOI : 10.1016/j.jneuroim.2006.06.029
Effect of Rituximab on the Peripheral Blood and Cerebrospinal Fluid B Cells in Patients With Primary Progressive Multiple Sclerosis, Archives of Neurology, vol.62, issue.2, pp.258-264, 2005. ,
DOI : 10.1001/archneur.62.2.258
B-Cell Depletion with Rituximab in Relapsing???Remitting Multiple Sclerosis, New England Journal of Medicine, vol.358, issue.7, pp.676-688, 2008. ,
DOI : 10.1056/NEJMoa0706383
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial, The Lancet, vol.378, issue.9805, pp.1779-1787, 2011. ,
DOI : 10.1016/S0140-6736(11)61649-8
Evaluation of safety and clinical activity of multiple doses of the anti-CD80 monoclonal antibody, galiximab, in patients with moderate to severe plaque psoriasis, Clinical Immunology, vol.111, issue.1, pp.28-37, 2004. ,
DOI : 10.1016/j.clim.2004.01.006
Phase I/II Study of Galiximab, an Anti-CD80 Antibody, for Relapsed or Refractory Follicular Lymphoma, Journal of Clinical Oncology, vol.23, issue.19, pp.4390-4398, 2005. ,
DOI : 10.1200/JCO.2005.09.018